Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Abbott Laboratories (NY: ABT )

113.86 -0.28 (-0.25%)
Official Closing Price Updated: 6:30 PM EST, Dec 12, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 3,763,867
Open 114.40
Bid (Size) 113.13 (2)
Ask (Size) 114.71 (1)
Prev. Close 114.14
Today's Range 113.30 - 114.78
52wk Range 99.71 - 121.64
Shares Outstanding 1,750,942,289
Dividend Yield 1.93%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Jim Cramer Says 'Keep Owning' This Energy Stock, Abbott Laboratories 'Legal Stuff' Is Behind Them
Jim Cramer discusses Occidental Petroleum, Cooper Companies, Energy Transfer, Abbott, Kinder Morgan, Advanced Drainage and Archer Aviation. 
Via Benzinga
“Cardiol Therapeutics (NASDAQ: CRDL) Heart Health Innovation – AVCO, GXAI, UPC, and More Stocks Driving Groundbreaking Advances”
Via AB Newswire

Performance

YTD
+3.65%
+3.65%
1 Month
-2.52%
-2.52%
3 Month
-2.35%
-2.35%
6 Month
+9.08%
+9.08%
1 Year
+6.73%
+6.73%

More News

Read More
Peering Into Abbott Laboratories's Recent Short Interest
Via Benzinga
ABBOTT LABORATORIES (NYSE:ABT) Technical Analysis observations.
Via Chartmill
2 High-Yield Dividend Stocks to Buy Now for a Lifetime of Passive Income
Via The Motley Fool
Analyst Ratings For Abbott Laboratories
Via Benzinga
Abbott Surges After Avoiding Another 'Eye-Popping' Verdict In Baby Formula Trial
Via Investor's Business Daily
P/E Ratio Insights for Abbott Laboratories
Via Benzinga
ABBOTT LABORATORIES (NYSE:ABT) Reveals Intriguing Technical Aspects. Here's What You Need to Know.
Via Chartmill
2 Dividend Kings to Buy for a Lifetime of Passive Income
Via The Motley Fool
What To Do After The Worst Week For Healthcare Stocks Since March 2020?
Via Talk Markets
Plant-Based API Market Poised To Hit $52 Billion By 2034, Driven By Psychedelics And Cannabinoids
Via Benzinga
3 Ultra-Safe Dividend Stocks That Have Been Paying Dividends for More Than 100 Years
Via The Motley Fool
Insulet Soars Out Of Buy Zone As 'Beat-And-Raise Cadence' Continues
Via Investor's Business Daily
2 Dividend Kings That Would Have Doubled Your Money in 5 Years
Via The Motley Fool
Want Decades of Passive Income? 2 Stocks to Buy Now and Hold Forever
Via The Motley Fool
What You Missed On Wall Street This Past Friday
Via Talk Markets
AbbVie’s Dividend Isn’t As Scary As It Looks
Via Talk Markets
These Are The Top Health Stocks to Own for Buy-and-Hold Investing
Via MarketBeat
Exposures COVID-19
3 Dividend Growth Stocks You Can Buy and Hold Forever
Via The Motley Fool
Beat the Nasdaq With This Cash-Gushing Dividend Stock
Via The Motley Fool
Want Decades of Passive Income? 2 Stocks to Buy Now and Hold Forever
Via The Motley Fool
MarketBeat Week in Review – 10/14 - 10/18
Via MarketBeat
Topics Artificial Intelligence Economy
Exposures Artificial Intelligence Interest Rates
Stock Market Rally At Highs; Taiwan Semi, ASML, Netflix In Focus: Weekly Review
Via Investor's Business Daily
Topics Stocks
Exposures US Equities
3 No-Brainer Pharmaceutical Stocks to Buy With $500 Right Now
Via The Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.